SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chang Betty Y

(Last)

(First)

(Middle)

C/O PHARMACYCLICS, INC.

995 EAST ARQUES AVENUE

(Street)

SUNNYVALE

94085

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/09/2013

3. Issuer Name and Ticker or Trading Symbol
PHARMACYCLICS INC [ PCYC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Research/Biology

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,650	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	11/23/2009⁽¹⁾	11/23/2019	Common Stock	17,000	$1.8	D
Stock Option (Right to Buy)	04/11/2010⁽²⁾	04/11/2020	Common Stock	15,000	$7.19	D
Stock Option (Right to Buy)	10/13/2010⁽³⁾	10/13/2020	Common Stock	15,000	$7.69	D
Stock Option (Right to Buy)	12/02/2011⁽⁴⁾	12/02/2021	Common Stock	10,000	$15.63	D

Explanation of Responses:

1. 16,675 of the shares underlying the options are vested and exercisable. The remaining 3,125 shares vest at the rate of 625 shares per month through November 23, 2013.

2. Option shares vest in a series of forty-eight (48) equal and successive monthly installments such that it is fully vested on April 11, 2014.

3. Option shares vest in a series of forty-eight (48) equal and successive monthly installments such that it is fully vested on October 13, 2014.

4. Option shares vest in a series of forty-eight (48) equal and successive monthly installments such that it is fully vested on December 2, 2015.

Remarks:

	/s/ Betty Y. Chang	07/11/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.